{
    "id": "clinical_knowledge-204",
    "question": "Which of the following is true in peripheral neuropathy?",
    "options": {
        "A": "Sensory loss is demonstrated in a stocking distribution",
        "B": "The tone is increased bilaterally in the legs",
        "C": "Reflexes are very brisk with reinforcement",
        "D": "Weakness is more marked proximally than distally"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, let's analyze the given options in relation to the characteristics of peripheral neuropathy.\\n\\nFirst, let's consider option A: Sensory loss is demonstrated in a stocking distribution. This is a classic characteristic of peripheral neuropathy, where sensory loss typically starts in the feet and toes and progresses proximally, resulting in a'stocking-and-glove' distribution. This is a hallmark feature of length-dependent axonal neuropathy, which is commonly seen in conditions such as diabetes.\\n\\nNext, let's examine option B: The tone is increased bilaterally in the legs. While muscle tone can be affected in various neuropathies, increased tone is not a typical characteristic of peripheral neuropathy. In fact, muscle tone is often decreased due to the loss of motor neurons.\\n\\nOption C: Reflexes are very brisk with reinforcement is also incorrect. In peripheral neuropathy, reflexes are often decreased or absent, particularly in the lower extremities, due to the involvement of sensory nerves.\\n\\nOption D: Weakness is more marked proximally than distally is also incorrect. In peripheral neuropathy, weakness is typically more pronounced distally, as the longest and largest axons are more susceptible to damage.\\n\\nTherefore, the correct answer is A: Sensory loss is demonstrated in a stocking distribution.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "Neurology_Adams_10406",
            "title": "Neurology_Adams",
            "content": "Chap. 2. Once having established that the patient has a disease of the peripheral nerves and having ascertained its clinical and electrophysiologic pattern and time course, one is usually able to determine its cause. This is accomplished most readily by allocating the case in question to one of the categories listed in Table 43-2, which classifies the peripheral nerve diseases syndromically according to their mode of evolution and clinical presentation. Our use of the terms acute, subacute, and chronic neuropathy must be explained. By acute, we mean evolution in terms of days, and by subacute, evolution in terms of weeks. Chronic is divided into two groups: one in which the neuropathy has progressed for a period of several months to a few years and another in which progression is over many years, most of which prove to have a genetic cause. It can be restated that these temporal properties are, with the topographic pattern, the main determinants in the categorization of neuropathy."
        },
        {
            "id": "Pathology_Robbins_4931",
            "title": "Pathology_Robbins",
            "content": "Toxic,Vasculitic, and Inherited Forms of Peripheral Neuropathy There are diverse other causes of peripherlal neuropathy ( Table 22.1 ), some of which merit brief discussion. Drugs and environmental toxins that interfere with axonal transport or cytoskeletal function often produce peripheral neuropathies. The longest axons are most susceptible, hence symptoms appear first and are most pronounced in the distal extremities. Peripheral nerves are damaged in many different forms of systemic vasculitis ("
        },
        {
            "id": "InternalMed_Harrison_21670",
            "title": "InternalMed_Harrison",
            "content": "Peripheral neuropathy usually becomes clinically evident after the patient reaches stage 4 CKD, although electrophysiologic and histologic evidence occurs earlier. Initially, sensory nerves are involved more than motor, lower extremities more than upper, and distal parts of the extremities more than proximal. The \u201crestless leg syndrome\u201d is characterized by ill-defined sensations of sometimes debilitating discomfort in the legs and feet relieved by frequent leg movement. If dialysis is not instituted soon after onset of sensory abnormalities, motor involvement follows, including muscle weakness. Evidence of peripheral neuropathy without another cause (e.g., diabetes mellitus) is an indication for starting renal replacement therapy. Many of the complications described above will resolve with dialysis, although subtle nonspecific abnormalities may persist."
        },
        {
            "id": "InternalMed_Harrison_31048",
            "title": "InternalMed_Harrison",
            "content": "Thus, peripheral neu-1. What Systems are Involved? It is important to determine if the ropathies can impair sensory, motor, or autonomic function, either patient\u2019s symptoms and signs are motor, sensory, autonomic, or a com-singly or in combination. Peripheral neuropathies are further classi-bination of these. If the patient has only weakness without any evidence fied into those that primarily affect the cell body (e.g., neuronopathy of sensory or autonomic dysfunction, a motor neuropathy, neuromusor ganglionopathy), myelin (myelinopathy), and the axon (axonopathy). cular junction abnormality, or myopathy should be considered. Some These different classes of peripheral neuropathies have distinct clinical peripheral neuropathies are associated with significant autonomic nerand electrophysiologic features. This chapter discusses the clinical vous system dysfunction. Symptoms of autonomic involvement include approach to a patient suspected of having a peripheral neuropathy, fainting"
        },
        {
            "id": "Neurology_Adams_10396",
            "title": "Neurology_Adams",
            "content": "Topographic and Clinical Patterns of Neuropathy (Table 43-1) At the outset it must be determined whether the neurologic findings correspond to one of the following syndromic patterns: 1. Polyneuropathy 2. Radiculopathy or polyradiculopathy 3. Neuronopathy\u2014motor or sensory 4. Mononeuropathy 5. Multiple mononeuropathies (mononeuropathy multiplex) 6. Plexopathy (involvement of multiple nerves in a plexus) A discussion of these patterns is given in Chap. 8, but the main facts are repeated here. In polyneuropathy, a generalized process affecting the peripheral nerves, weakness is relatively symmetrical from the beginning and progresses bilaterally; reflexes are lost in affected parts but particularly at the ankles; sensory complaints and loss of sensation are most pronounced distally, and in the feet before the hands in most cases."
        },
        {
            "id": "Neurology_Adams_10329",
            "title": "Neurology_Adams",
            "content": "In this single chapter, an attempt is made to provide an overview of the very large and difficult subject of peripheral nerve disease. Because the structure and function of the peripheral nervous system are relatively simple, one might suppose that our knowledge of its diseases would be fairly complete. Such is not the case. For example, when a group of patients with chronic polyneuropathy were investigated intensively in a highly specialized center for the study of peripheral nerve diseases several decades ago, a suitable explanation for their condition could not be found in 24 percent (Dyck et al, 1981) and equally discouraging figures prevail in our clinics today despite genetic testing. Moreover, the physiologic basis of many neuropathic symptoms continues to be elusive and in several of the neuropathies the pathologic changes have not been fully determined. However, rapidly advancing techniques in the fields of immunology and genetics are now clarifying entire categories of"
        },
        {
            "id": "Neurology_Adams_10371",
            "title": "Neurology_Adams",
            "content": "in Chap. 8) Most polyneuropathies cause impairment of both motor and sensory functions, but one is often affected more than the other. In the toxic and metabolic neuropathies, sensory loss usually exceeds weakness. These differences are emphasized in the descriptions of individual peripheral nerve diseases in later parts of the chapter."
        },
        {
            "id": "Neurology_Adams_10853",
            "title": "Neurology_Adams",
            "content": "Table 43-7 lists the laboratory tests that we have found useful in the investigation of this group of neuropathies, with electrophysiology being most valuable. Diagnosis of Late Chronic Polyneuropathy"
        },
        {
            "id": "InternalMed_Harrison_31050",
            "title": "InternalMed_Harrison",
            "content": "Peripheral NeuropathyChapter 459Patient Complaint: ? Neuropathy History and examination compatible with neuropathy? Mononeuropathy Mononeuropathy multiplex Polyneuropathy Evaluation of other \u02dcdisorder or \u02dcreassurance and follow-up EDx Is the lesion axonal \u02dcor demyelinating? Is entrapment or \u02dccompression present? Is a contributing systemic disorder present? Axonal Demyelinating \u02dcwith focal \u02dcconduction block Axonal Demyelinating Consider \u02dcvasculitis or other multifocal \u02dcprocess Consider \u02dcmultifocal \u02dcform of \u02dcCIDP Subacute \u02dccourse (months) Chronic \u02dccourse (years) Uniform slowing, \u02dcchronic Nonuniform slowing, conduction block Decision on need \u02dcfor surgery (nerve repair, \u02dctransposition, or release \u02dcprocedure) Possible \u02dcnerve \u02dcbiopsy Test for paraprotein, \u02dcHIV, Lyme disease Review history for toxins; test for associated systemic disease or intoxication Test for paraprotein, if negative Review family history; examine family members; genetic testing If chronic or \u02dcsubacute: CIDP If"
        },
        {
            "id": "Neurology_Adams_10330",
            "title": "Neurology_Adams",
            "content": "of the neuropathies the pathologic changes have not been fully determined. However, rapidly advancing techniques in the fields of immunology and genetics are now clarifying entire categories of neuropathic disease. Also, effective forms of treatment for several peripheral neuropathies have been introduced, making accurate diagnosis imperative. For these reasons, clinicians now find the peripheral neuropathies among the most challenging and gratifying categories of neurologic disease."
        },
        {
            "id": "InternalMed_Harrison_15296",
            "title": "InternalMed_Harrison",
            "content": "evidence of peripheral nerve disease. Presenting symptoms are usually painful burning sensations in the feet and lower extremities. Findings on examination include a stocking-type sensory loss to pinprick, temperature, and touch sensation and a loss of ankle reflexes. Motor changes are mild and are usually limited to weakness of the intrinsic foot muscles. Response of this condition to antiretrovirals has been variable, perhaps because antiretrovirals are responsible for the problem in some instances. When due to dideoxynucleoside therapy, patients with lower extremity peripheral neuropathy may complain of a sensation that they are walking on ice. Other entities in the differential diagnosis of peripheral neuropathy include diabetes mellitus, vitamin B12 deficiency, and side effects from metronidazole or dapsone. For distal symmetric polyneuropathy that fails to resolve following the discontinuation of dideoxynucleosides, therapy is symptomatic; gabapentin, carbamazepine, tricyclics,"
        },
        {
            "id": "Neurology_Adams_10395",
            "title": "Neurology_Adams",
            "content": "The clinician is faced initially with several problems that can be solved sequentially when dealing with this group of diseases: (1) establishing the existence of disease of the peripheral nervous system and differentiating it from a process of the central nervous system, neuromuscular junction or the muscles; (2) distinguishing by clinical examination which of the main topographic syndromes is being displayed; (3) determining by examination and nerve conduction studies if the problem is predominantly motor or sensory or autonomic in nature or is of mixed type and whether the myelin sheath, the axon, or cell body (motor or sensory neurons) is the target of disease; and (4) assessing if the neuropathy is acquired or hereditary in nature. When taken together, these features limit the likely etiologic diagnoses from a vast list of possibilities. Topographic and Clinical Patterns of Neuropathy (Table 43-1)"
        },
        {
            "id": "Neurology_Adams_8872",
            "title": "Neurology_Adams",
            "content": "diabetes, or other late-life neuropathy. Sensory evoked potentials are mildly abnormal in a proportion of patients, but the explanation for this finding is unclear. (Sensory complaints and minimal sensory loss have been commented on above.)"
        },
        {
            "id": "Pathology_Robbins_4930",
            "title": "Pathology_Robbins",
            "content": "Lumbosacral radiculopathy usually manifests with asymmetric pain that can progress to lower extremity weakness and muscle atrophy. Distal symmetric sensorimotor polyneuropathy is the most common form of diabetic neuropathy. Sensory axons are more severely affected than motor axons, resulting in a clinical presentation dominated by paresthesias and numbness. This form of diabetic polyneuropathy results from the length-dependent degeneration of peripheral nerves and does not neatly fit into the axonal or demyelinating category but instead often exhibits features of both. The pathogenesis of diabetic neuropathy is complex; accumulation of advanced glycosylation end products resulting from hyperglycemia, increased levels of reactive oxygen species, microvascular changes, and changes in axonal metabolism, all have been implicated. Strict glycemic control is the best form of therapy. Toxic,Vasculitic, and Inherited Forms of Peripheral Neuropathy"
        },
        {
            "id": "Pediatrics_Nelson_3843",
            "title": "Pediatrics_Nelson",
            "content": "There are many peripheral nerve diseases in childhood, but the most classic presentations are: Guillain-Barr\u00e9 syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), hereditary motor sensory neuropathy (HMSN), and tick paralysis. Peripheral neuropathies produced by diabetes mellitus, alcoholism, chronic renal failure, exposure to toxins, vasculitis, and the effects of neoplasm are common in adults but are rare in children. Guillain-Barr\u00e9 syndrome (acute inflammatory demyelinating polyradiculoneuropathy) is a postinfectious autoimmune peripheral neuropathy that can occur about 10 days after a respiratory or gastrointestinal infection (classically Mycoplasma pneumonia or Campylobacter jejuni). It occurs in people of all ages and is the most common cause of acute flaccid paralysis in children."
        },
        {
            "id": "Neurology_Adams_243",
            "title": "Neurology_Adams",
            "content": "The main effect of disease processes that preferentially injure axons, as mentioned above, is a reduction in the CMAP amplitude (Fig. 2-12B). However, some processes affect the fastest-conducting, large-diameter fibers and also usually reduce the conduction velocity because the remaining thinner fibers conduct more slowly. In most neuropathies, all the axons are affected either by a fairly uniform \u201cdying-back\u201d phenomenon or by wallerian degeneration as described in Chap. 43, and nerve conduction velocities are then less affected. This is true, for example, in typical alcoholic-nutritional, carcinomatous, uremic, diabetic, and other metabolic neuropathies, in which conduction velocities range from the low-normal range to mildly slowed. By contrast, demyelinating neuropathies (see Chap. 46) show marked slowing of conduction and, in the case of the acquired demyelinating diseases, there is also dispersion of the motor action potential and a characteristic conduction block (Fig. 2-12C)."
        },
        {
            "id": "Pharmacology_Katzung_6379",
            "title": "Pharmacology_Katzung",
            "content": "Overt peripheral neuropathy may appear after chronic high-dose lead exposure, usually following months to years of blood lead concentrations higher than 100 mcg/dL. Predominantly motor in character, the neuropathy may present clinically with painless weakness of the extensors, particularly in the upper extremity, resulting in classic wrist-drop. Preclinical signs of lead-induced peripheral nerve dysfunction may be detectable by electrodiagnostic testing. B. Blood"
        },
        {
            "id": "Neurology_Adams_1221",
            "title": "Neurology_Adams",
            "content": "As most polyneuropathies affect mixed nerves, the sensory changes are accompanied by varying degrees of motor and reflex loss. Usually the sensory impairment is roughly symmetrical and the predominant symptoms are numbness and paresthesias. Because in most types of polyneuropathy the longest and largest axons are the most affected (\u201clength dependent,\u201d axonal neuropathy), sensory loss begins in, and is most severe over the feet and legs and, if the upper limbs are affected, over the hands. As the polyneuropathy progresses the margin of sensory loss \u201cascends,\u201d meaning it moves proximally on the limbs. The term glove-and-stocking, employed to describe the distribution of sensory loss of polyneuropathy, draws attention to the predominantly distal pattern of involvement but does not convey that the change from normal to impaired sensation is characteristically gradual. (In psychogenic sensory loss, by contrast, the border between normal and absent sensation is usually sharply defined.) The"
        },
        {
            "id": "Neurology_Adams_9339",
            "title": "Neurology_Adams",
            "content": "The notion that the neurologic manifestation of beriberi is essentially a peripheral neuropathy was established in the late nineteenth century by the studies of the Dutch investigators Eijkman, Pekelharing and Winkler, and"
        },
        {
            "id": "Neurology_Adams_10962",
            "title": "Neurology_Adams",
            "content": "Ecker AD, Woltman WH: Meralgia paresthetica: A report of one hundred and fifty cases. JAMA 110:1650, 1938. Eftimov F, Veremuelen M, Doorn PA, et al: Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment. Neurology 78:1079, 2012. England JD, Asbury AK: Peripheral neuropathy. Lancet 363:2151, 2004. England JD, Gronseth GS, Franklin G, et al: Evaluation of distal symmetric polyneuropathy: The role of laboratory and genetic testing (an evidence-based review). Muscle Nerve 39:116, 2009. Faber CG, Hoeijmakers JG, Ahn HS, et al: Gain of function Nav1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 71:26, 2012. Fagerberg SE: Diabetic neuropathy: A clinical and histological study on the significance of vascular affections. Acta Med Scand 164(Suppl 345):1, 1959. Falls HF, Jackson JH, Carey JG, et al: Ocular manifestations of hereditary primary systemic amyloidosis. Arch Ophthalmol 54:660, 1955."
        },
        {
            "id": "Pathology_Robbins_4924",
            "title": "Pathology_Robbins",
            "content": "http://ebooksmedicine.net neuropathiesresultingfromvascularinjury. of damage to random internodes is best visualized when examining a series of internodes along individual axons in teased fiber preparations ( Fig. 22.2A Peripheral neuropathies exhibit several anatomic patterns. Polyneuropathies usually affect peripheral nerves in a symmetric, length-dependent fashion. Axonal loss is typically more pronounced in the distal segments of the longest nerves. Patients commonly present with loss of sensation and paresthesias that start in the toes and spread upward. By the time the sensory changes reach the level of the knees, the hands are also affected, resulting in a picture described as \u201cstocking-and-glove\u201d distribution. This pattern is often encountered with toxic and metabolic damage."
        },
        {
            "id": "Neurology_Adams_10362",
            "title": "Neurology_Adams",
            "content": "It is not surprising that weakness in various patterns and degrees is a feature of almost all neuropathies. The degree of weakness is proportional to the number of axons or motor neurons affected. Polyneuropathies that are the result of axonal damage are characterized foremost by a relatively symmetric distribution of weakness that is, moreover, distal because the pathologic changes begin in the far distal parts of the largest and longest nerves and advance along the affected fibers toward their nerve cell bodies (dying-back neuropathy, or \u201cdistal axonopathy\u201d). The muscles of the feet and legs are typically affected earlier and more severely than those of the hands and forearms. In milder forms of axonal disease, only the feet and lower legs are involved. Truncal and cranial muscles are usually the last to yield, and then only in severe cases. This represents the \u201clength-dependent\u201d pattern that is typical of axonal degeneration. The nutritional, metabolic, and toxic neuropathies"
        },
        {
            "id": "InternalMed_Harrison_31129",
            "title": "InternalMed_Harrison",
            "content": "A generalized sensorimotor neuropathy characterized by numbness, tingling, and minor weakness in the distal aspects of primarily the lower limbs commonly occurs in patients with chronic liver failure. EDx studies are consistent with a sensory greater than motor axonopathy. Sural nerve biopsy reveals both segmental demyelination and axonal loss. It is not known if hepatic failure in isolation can cause peripheral neuropathy, as the majority of patients have liver disease secondary to other disorders, such as alcoholism or viral hepatitis, which can also cause neuropathy."
        },
        {
            "id": "InternalMed_Harrison_28033",
            "title": "InternalMed_Harrison",
            "content": "Diabetic neuropathy occurs in ~50% of individuals with long-standing type 1 and type 2 DM. It may manifest as polyneuropathy, mononeuropathy, and/or autonomic neuropathy. As with other complications of DM, the development of neuropathy correlates with the duration of diabetes and glycemic control. Additional risk factors are body mass index (BMI) (the greater the BMI, the greater the risk of neuropathy) and smoking. The presence of CVD, elevated triglycerides, and hypertension is also associated with diabetic peripheral neuropathy. Both myelinated and unmyelinated nerve fibers are lost. Because the clinical features of diabetic neuropathy are similar to those of other neuropathies, the diagnosis of diabetic neuropathy should be made only after other possible etiologies are excluded (Chap. 459)."
        },
        {
            "id": "Neurology_Adams_10551",
            "title": "Neurology_Adams",
            "content": "Isolated involvement of practically all the major peripheral nerves has been described in diabetes, but the ones most frequently affected are the femoral, sciatic, and peroneal nerves, in that order. Rarely is a nerve in the upper extremity affected. As mentioned, the acute mononeuropathies, both cranial and peripheral, are presumably a result of infarction of the nerve, but it is only in pathologic studies of the third nerve that this basis has been established. Recovery is the rule but may take many months."
        },
        {
            "id": "Neurology_Adams_10361",
            "title": "Neurology_Adams",
            "content": "There are a number of motor, sensory, reflex, autonomic, and trophic symptoms and signs that are typical of peripheral nerve disease. Grouping them into syndromes based on their temporal and topographic features has proved to be of great value in clinical diagnosis. Although motor, sensory, reflex, and trophic changes are taken together to determine specific diagnosis, each element of the neuropathic diseases is given in the following pages. Impairment of Motor Function"
        },
        {
            "id": "Neurology_Adams_9314",
            "title": "Neurology_Adams",
            "content": "As Korsakoff pointed out, signs of peripheral neuropathy are common, found in more than 80 percent of patients with the Wernicke-Korsakoff syndrome. In most, the neuropathic disease is mild and does not account for the disorder of gait, but in some it may be severe and particularly painful. In a small number, retrobulbar optic neuropathy is added. Despite the frequency of peripheral neuropathy, overt signs of beriberi heart disease are rare. However, indications of disordered cardiovascular function such as tachycardia, exertional dyspnea, postural hypotension, and minor electrocardiographic abnormalities are frequent; occasionally, the patient dies suddenly following only slight exertion. These patients may show an elevation of cardiac output associated with low peripheral vascular resistance, abnormalities that revert to normal after the administration of thiamine. Postural hypotension and syncope are common findings in Wernicke disease and are probably a result of impaired function"
        },
        {
            "id": "Neurology_Adams_10549",
            "title": "Neurology_Adams",
            "content": "presumably as a result of sensory analgesia, trophic changes, and repetitive injury. (Foot ulcerations are more common simply as a result of the microvascular disease of skin in diabetic patients.) Muscle weakness is usually mild, but in some patients a distal sensory neuropathy is combined with a proximal weakness and wasting of the types mentioned earlier. Treatment of the acral pain may be a major problem and is discussed further on."
        },
        {
            "id": "Neurology_Adams_10543",
            "title": "Neurology_Adams",
            "content": "Approximately 15 percent of patients with diabetes have symptoms and signs of polyneuropathy, but nearly 50 percent of cross-sectional population samples have evidence of peripheral nerve damage as judged by nerve conduction abnormalities. The duration of diabetes is perhaps the most important factor. Fewer than 10 percent of patients have clinically evident polyneuropathy at the time of discovery of diabetes, but this figure rises to 50 percent after 25 years. The presence of diabetic retinopathy is associated with higher incidences of neuropathy. It is not surprising, therefore, that neuropathy is most common in diabetics older than 50 years; it is infrequent in those younger than age 30 years and is rare in childhood. Dyck and colleagues (1993) studied diabetics in Rochester, Minnesota, and found that 54 percent with type 1 (insulin-deficient) and 45 percent with type 2 (insulin-resistant) had polyneuropathy. The percentages were lower when patients were selected on the basis of"
        },
        {
            "id": "InternalMed_Harrison_28034",
            "title": "InternalMed_Harrison",
            "content": "Polyneuropathy/Mononeuropathy The most common form of diabetic neuropathy is distal symmetric polyneuropathy. It most frequently presents with distal sensory loss and pain, but up to 50% of patients do not have symptoms of neuropathy. Hyperesthesia, paresthesia, and dysesthesia also may occur. Any combination of these symptoms may develop as neuropathy progresses. Symptoms may include a sensation of numbness, tingling, sharpness, or burning that begins in the feet and spreads proximally. Neuropathic pain develops in some of these individuals, occasionally preceded by improvement in their glycemic control. Pain typically involves the lower extremities, is usually present at rest, and worsens at night. Both an acute (lasting <12 months) and a chronic form of painful diabetic neuropathy have been described. The acute form is sometimes treatment-related, occurring in the context of improved glycemic control. As diabetic neuropathy progresses, the pain subsides and eventually disappears,"
        },
        {
            "id": "Neurology_Adams_10651",
            "title": "Neurology_Adams",
            "content": "proves that the lesion is located proximal to the dorsal root ganglion and spares the peripheral sensory axons. Loss of the F and H late responses is also typical of polyradiculopathies. The proximal location of the lesion can be further corroborated by early evidence of weakness and denervation in the paraspinal, gluteal, or rhomboid muscles, which are supplied by nerves that arise very proximally from the roots. In axonal cases of neuropathy, these proximal muscles are the last to be involved."
        },
        {
            "id": "Neurology_Adams_10973",
            "title": "Neurology_Adams",
            "content": "Kaplan JG, Rosenberg R, Reinitz E, et al: Invited review: Peripheral neuropathy in Sj\u00f6gren\u2019s syndrome. Muscle Nerve 13:573, 1990. Karam C, Klein CJ, Dispenzieri A, et al: Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome. Neurology 2015;84, 1981. Katirji MB, Wilbourn AJ: Common peroneal mononeuropathy: A clinical and electrophysiologic study of 116 lesions. Neurology 38:1723, 1988. Katz JS, Saperstein DS, Gronseth D, et al: Distal acquired demyelinating symmetric neuropathy. Neurology 54:615, 2000. Kernohan JW, Woltman HW: Amyloid neuritis. Arch Neurol Psychiatry 47:132, 1942. Kikta DG, Breuer AC, Wilbourn AJ: Thoracic root pain in diabetes: The spectrum of clinical and electromyographic findings. Ann Neurol 11:80, 1982. King R: Atlas of Peripheral Nerve Pathology. London, Arnold, 1999. Klein CJ, Duan X, Shy ME: Inherited neuropathies: Clinical overview and update. AANEM Monograph. Muscle Nerve 48:604, 2013."
        }
    ],
    "scores": [
        0.03406889610299126,
        0.028009813657339795,
        0.026869038041604412,
        0.025757331214461304,
        0.025268440709617177,
        0.02470685630530373,
        0.024178092289547398,
        0.023735028346974708,
        0.023669222719709056,
        0.0230886760298525,
        0.022633385133385135,
        0.021572134175149252,
        0.02145998448667199,
        0.020758346581875996,
        0.0196126746346355,
        0.018554485464597825,
        0.018041446566436407,
        0.0180238694487294,
        0.01770873786407767,
        0.017542515703998774,
        0.017116145271485077,
        0.017028985507246377,
        0.016986496090973704,
        0.016959082381609147,
        0.016750305167503053,
        0.01655982905982906,
        0.016237901171676006,
        0.01604380212644044,
        0.016009695114172728,
        0.015891811043250655,
        0.01577905717300657,
        0.01563920712856883
    ],
    "execution_time": 46.96389961242676
}